MinervaX raises €72M to develop Group B Streptococcus vaccine
MinervaX ApS, a privately held Danish biotech company developing a novel vaccine against Group B…
December 15, 2022 - 2 minutes
MinervaX ApS, a privately held Danish biotech company developing a novel vaccine against Group B…